SubsidieMeesters logoSubsidieMeesters
ProjectenRegelingenAnalyses

Development of a non-invasive medical device to measure the skin biomechanical properties: assessment of the commercial feasibility

AssesSkin aims to develop a non-invasive medical device for assessing skin biomechanical properties, enhancing personalized treatment in dermatology and cosmetics while addressing regulatory pathways.

Subsidie
€ 150.000
2024

Projectdetails

Introduction

Skin pathologies including wounds, scars, and tumors represent important public health issues (e.g., melanoma is the first cancer in terms of increasing frequency). Moreover, skin firmness is an essential property aimed at by cosmetic products. However, skin assessment methods remain based on empirical considerations, and it is still difficult to determine the skin biomechanical properties, which prevents developing a personalized medicine approach.

Need for a Medical Device

Such a medical device is needed by physicians to adapt the therapeutic strategy and by cosmetic manufacturers to develop and validate their products, and to propose the optimal product in a customer-specific manner.

Project Overview

AssesSkin is based on results obtained in the ERC CoG project BoneImplant and aims at developing and validating a medical device consisting of a decision support system allowing for the assessment of skin biomechanical properties.

Objectives

The objectives of AssesSkin are:

  1. To achieve a minimum viable product that will be validated in vitro and in vivo.
  2. To investigate its commercial potential and design an exploitation strategy via spin-off creation or licensing.

We will explore the possibility of licensing the technology to ImpacTell, an already existing spin-off of the same laboratory.

Methodology

The originality is to use an impact-based measurement method, which allows obtaining a non-invasive, cheap, and easy-to-use medical device.

Regulatory Considerations

Regulatory issues will be at the heart of the development, and we will work to clear the regulatory pathway of the future medical device.

Team Composition

The team is constituted of members with complementary skills, including:

  • Engineers
  • A business developer
  • A dermatologist
  • A plastic surgeon

Impact and Vision

AssesSkin will allow the promotion of innovative solutions and services in dermatology, plastic surgery, and the cosmetic industry. The long-term vision is for the technology to become a reference in these fields. Strong impacts are associated with AssesSkin, particularly for patients, physicians, and cosmetic manufacturers.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 150.000
Totale projectbegroting€ 150.000

Tijdlijn

Startdatum1-4-2024
Einddatum30-9-2025
Subsidiejaar2024

Partners & Locaties

Projectpartners

  • CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRSpenvoerder

Land(en)

France

Inhoudsopgave

European Research Council

Financiering tot €10 miljoen voor baanbrekend frontier-onderzoek via ERC-grants (Starting, Consolidator, Advanced, Synergy, Proof of Concept).

Bekijk regeling

Vergelijkbare projecten binnen European Research Council

ProjectRegelingBedragJaarActie

Development of an instrumented hammer to assess the stability of hip implant during surgery: assessment of the commercial feasibility

Impactor aims to develop a decision support system for assessing hip implant stability using an instrumented orthopedic hammer, enhancing surgical strategies and commercial potential in orthopedic surgery.

ERC Proof of...€ 150.000
2022
Details

Personalised Bioelectronics for Epithelial Repair

ProBER aims to develop personalized bioelectronic wound dressings using conformal DC electrodes to enhance healing speed and efficiency in chronic wounds, preparing for clinical studies.

ERC Proof of...€ 150.000
2023
Details

Intelligent Device and Computational Software to Control Mechanical Stress and Deformation for Biological Testing

ISBIOMECH aims to develop a novel intelligent system for controlling mechanical environments in biological testing, enhancing in-vitro therapies and drug discovery for various pathologies.

ERC Proof of...€ 150.000
2023
Details

3D screening system to cultivate tissue and automatically stimulate and quantify its mechanical properties

The project aims to develop the TissMec system for automated 3D human tissue creation and screening to expedite drug candidate evaluation and improve the drug development process.

ERC Proof of...€ 150.000
2024
Details

Overcoming limits for pre-clinical small volume liquid delivery into skin and inflammation quantification

This project aims to validate the BuBble Gun injection method using Skin-On-Chip technology for localized drug testing in chronic skin diseases, paving the way for innovative treatment delivery.

ERC Proof of...€ 150.000
2025
Details
ERC Proof of...

Development of an instrumented hammer to assess the stability of hip implant during surgery: assessment of the commercial feasibility

Impactor aims to develop a decision support system for assessing hip implant stability using an instrumented orthopedic hammer, enhancing surgical strategies and commercial potential in orthopedic surgery.

ERC Proof of Concept
€ 150.000
2022
Details
ERC Proof of...

Personalised Bioelectronics for Epithelial Repair

ProBER aims to develop personalized bioelectronic wound dressings using conformal DC electrodes to enhance healing speed and efficiency in chronic wounds, preparing for clinical studies.

ERC Proof of Concept
€ 150.000
2023
Details
ERC Proof of...

Intelligent Device and Computational Software to Control Mechanical Stress and Deformation for Biological Testing

ISBIOMECH aims to develop a novel intelligent system for controlling mechanical environments in biological testing, enhancing in-vitro therapies and drug discovery for various pathologies.

ERC Proof of Concept
€ 150.000
2023
Details
ERC Proof of...

3D screening system to cultivate tissue and automatically stimulate and quantify its mechanical properties

The project aims to develop the TissMec system for automated 3D human tissue creation and screening to expedite drug candidate evaluation and improve the drug development process.

ERC Proof of Concept
€ 150.000
2024
Details
ERC Proof of...

Overcoming limits for pre-clinical small volume liquid delivery into skin and inflammation quantification

This project aims to validate the BuBble Gun injection method using Skin-On-Chip technology for localized drug testing in chronic skin diseases, paving the way for innovative treatment delivery.

ERC Proof of Concept
€ 150.000
2025
Details

Vergelijkbare projecten uit andere regelingen

ProjectRegelingBedragJaarActie

SKIN MICROBIAL DEVICES

SKINDEV aims to develop Smart Skin Microbial Devices for non-invasive monitoring and treatment of atopic dermatitis through innovative sensing technologies and genetic engineering.

EIC Pathfinder€ 1.718.408
2023
Details

Revolutionizing Skin Health with our Advanced Engineered Biotherapeutics

The SkinEngineering project aims to advance a patented biotherapeutic technology using genetically engineered skin bacteria for effective acne treatment, targeting regulatory validation and commercialization.

EIC Transition€ 2.499.999
2025
Details

Development of the Rehab Move

Het project ontwikkelt de "Rehab Move", een flexibele wearable die blessures voorkomt en trainingseffectiviteit verhoogt door interne en externe bewegingsdata te monitoren en te analyseren.

Mkb-innovati...€ 350.000
2018
Details

SportsLapp

Het project ontwikkelt een meetsysteem met sensoren voor het verbeteren van revalidatie en het verminderen van sportblessures.

Mkb-innovati...€ 206.010
2023
Details

Mid-infrared Wearable for Non-invasive biomarker monitoring

The project aims to develop a wearable device using a miniature Mid-Infrared spectrometer for non-invasive biomarker detection in metabolic syndrome, enhancing early diagnosis and management.

EIC Pathfinder€ 3.991.297
2024
Details
EIC Pathfinder

SKIN MICROBIAL DEVICES

SKINDEV aims to develop Smart Skin Microbial Devices for non-invasive monitoring and treatment of atopic dermatitis through innovative sensing technologies and genetic engineering.

EIC Pathfinder
€ 1.718.408
2023
Details
EIC Transition

Revolutionizing Skin Health with our Advanced Engineered Biotherapeutics

The SkinEngineering project aims to advance a patented biotherapeutic technology using genetically engineered skin bacteria for effective acne treatment, targeting regulatory validation and commercialization.

EIC Transition
€ 2.499.999
2025
Details
Mkb-innovati...

Development of the Rehab Move

Het project ontwikkelt de "Rehab Move", een flexibele wearable die blessures voorkomt en trainingseffectiviteit verhoogt door interne en externe bewegingsdata te monitoren en te analyseren.

Mkb-innovatiestimulering Topsectoren R&D Samenwerking
€ 350.000
2018
Details
Mkb-innovati...

SportsLapp

Het project ontwikkelt een meetsysteem met sensoren voor het verbeteren van revalidatie en het verminderen van sportblessures.

Mkb-innovatiestimulering Topsectoren R&D Samenwerking
€ 206.010
2023
Details
EIC Pathfinder

Mid-infrared Wearable for Non-invasive biomarker monitoring

The project aims to develop a wearable device using a miniature Mid-Infrared spectrometer for non-invasive biomarker detection in metabolic syndrome, enhancing early diagnosis and management.

EIC Pathfinder
€ 3.991.297
2024
Details

SubsidieMeesters logoSubsidieMeesters

Vind en verken subsidieprojecten in Nederland en Europa.

Links

  • Projecten
  • Regelingen
  • Analyses

Suggesties

Heb je ideeën voor nieuwe features of verbeteringen?

Deel je suggestie
© 2025 SubsidieMeesters. Alle rechten voorbehouden.